FDA recall record

Boehringer Ingelheim Roxane Azathioprine Tablets USP, 50 mg, 100 count bottle recall — FDA D-1313-2014

Labeling: Incorrect or Missing Lot and/or Exp Date: This recall is being conducted because the product was given 36 month expiration dates instead of the…

Class IIIclassification
D-1313-2014official record ID
May 14, 2014report date

Recall record at a glance

Official recordD-1313-2014
CategoryDrug Recalls
ClassificationClass III
FDA record statusTerminated
Recalling firmBoehringer Ingelheim Roxane Inc.
Report dateMay 14, 2014
Recall initiation dateApr 4, 2014
Quantity8,304 bottles
LocationColumbus, OH, United States

Official product description

Azathioprine Tablets USP, 50 mg, 100 count bottle, Rx only, Roxanne Laboratories, Inc., Columbus, Ohio, 43216, NDC 0054-4084-25

Why the product was recalled

Labeling: Incorrect or Missing Lot and/or Exp Date: This recall is being conducted because the product was given 36 month expiration dates instead of the filed 24 months.

Distribution information

Nationwide

How to read the classification

FDA Class III generally covers situations in which use of or exposure to the product is not likely to cause adverse health consequences. The classification displayed here is taken from the FDA enforcement record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.

Related recall records

Other records from the same recalling company are shown first when available.

DrugAug 5, 2015

COMBIVENT RESPIMAT recall — FDA D-1279-2015

Defective Delivery System: Inhalers do not spray properly, emitting either no spray or a short transient spray.

Class IIFDA: TerminatedBoehringer Ingelheim Roxane Inc.
DrugApr 16, 2014

Spiriva HandiHaler recall — FDA D-1230-2014

Defective Delivery System: Potential for dose delivery out of specification due to interation of the drug product powder with the lubricant on the interior of the capsule shell.

Class IIIFDA: TerminatedBoehringer Ingelheim Roxane Inc.